Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Raymond James Adjusts Price Target on Johnson & Johnson to $178 from $183, Keeps Outperform Rating

10/20/2021 | 11:31am EST


ę MT Newswires 2021
All news about JOHNSON & JOHNSON
01/24Morgan Stanley Adjusts Johnson & Johnson's Price Target to $175 from $187, Keeps Equalw..
MT
01/24L3Harris Technologies Names Michelle Turner As CFO, Senior Vice President
MT
01/23Switzerland OKs COVID-19 Booster Dose For Children Aged 12 to 15
MT
01/21Global Calendar For Week Ending January 28
MT
01/21CDC : Vaccines less effective against Omicron, but still reduce risk for serious illness
AQ
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/17Johnson & Johnson Statement on New Mexico Opioid Settlement Agreement
AQ
01/17MARKETSCREENER’S WORLD PRESS REVIEW : January 17, 2022
01/17Midatech Pharma, Janssen Extend R&D Partnership On Experimental Medicine
MT
01/14European Medicines Agency Asks AstraZeneca, Johnson & Johnson To Add Spinal Inflammatio..
MT
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 304 M - -
Net income 2021 22 542 M - -
Net cash 2021 815 M - -
P/E ratio 2021 19,3x
Yield 2021 2,55%
Capitalization 429 B 429 B -
EV / Sales 2021 4,54x
EV / Sales 2022 4,21x
Nbr of Employees 134 500
Free-Float -
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 162,97 $
Average target price 182,83 $
Spread / Average Target 12,2%
EPS Revisions
Managers and Directors
Joaquin Duato Chief Executive Officer & Director
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Alex Gorsky Executive Chairman
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON-4.73%429 034
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-12.00%220 356
NOVO NORDISK A/S-14.11%219 146